Viatris (VTRS) Stock Price & Analysis

VTRS$20.82+0.15 +0.73%
Drug Manufacturers - Specialty & GenericLarge Cap
Compare
Market cap$23.87BEnterprise value$35.65BRevenue (TTM)$14.73BMarket positionTop 25%

Score

33
Bearish
Value
48
Quality
25
Growth
27

AI Analysis

Snapshot

Viatris doesn’t screen as a clean setup today — Stocklytics 33/100 leaves more to prove. Under the hood: revenue compounding ~-4% annually over recent years, plus 2.3% dividend yield.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

48
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

27
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

25
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Viatris Inc. (VTRS) last printed $20.82. Equity value is $23.87B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$11.08B$11.91B$11.43B$11.5B$11.95B$17.89B$16.26B$15.43B$14.74B$14.3B

About

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors. Beyond manufacturing medicines, Viatris supports patient well-being through additional services such as diagnostic clinics, educational seminars, and digital tools designed to assist with health management. Products are made available in various forms, including oral solids, injectable solutions, complex dosage formulations, and raw APIs. Viatris distributes these to a broad clientele globally, including retail pharmacies, wholesalers, government bodies, insurance providers, and institutional healthcare facilities. The distribution network involves pharmaceutical wholesalers, retail and institutional pharmacies, mail-order and e-commerce platforms, and specialty pharmacies. The company's extensive portfolio includes prominent brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, Yupelri, Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV. Its biosimilar franchises feature products such as Fulphila, Ogivri, Hulio, and SEMGLEE. Viatris Inc. also fosters innovation through strategic collaborations and licensing agreements with partners including Revance Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Theravance Biopharma, Inc., Biocon Ltd., and Fujifilm Kyowa Kirin Biologics Co. Ltd. Founded in 1961, Viatris Inc. maintains its corporate headquarters in Canonsburg, Pennsylvania.

Viatris (VTRS) Stock Price & Analysis

VTRS price $20.82 +0.15 +0.73%

Ticker
VTRS
Price
$20.82
Change
+0.15 +0.73%
Market cap
$23.87B
Forward P/E
7.79
Dividend yield
2.31%
Beta
0.87
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
33
Value
48
Quality
25
Growth
27

Stocklytics score rationale: value 48, quality 25, growth 27.

AI Score 45. Viatris Inc. has a market cap of approximately $21.86 billion and a negative net profit margin of -2.79%

Fair value

VTRS fair value $65.54. Price $20.82. Price is 68% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 76% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 30.0, a blend of the Healthcare median (30.7) and the stock's own 10-year median (39.7). How we calculate it →

Model uncertainty high for this stock

Compare VTRS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-25—0.60—3.76B
2026-11-050.710.643.75B3.79B
2026-08-060.690.603.76B3.68B
2026-05-070.590.503.52B3.36B
2026-02-260.570.533.70B3.53B
2025-11-060.670.623.76B3.62B
2025-08-070.620.563.58B3.47B
2025-05-080.500.493.25B3.24B
2025-02-270.540.613.53B3.60B
2024-11-070.750.683.74B3.72B
2024-08-080.690.683.80B3.78B
2024-05-090.670.673.66B3.69B
2024-02-280.610.673.84B3.87B
2023-11-070.780.743.94B3.87B
2023-08-070.750.713.92B3.87B
2023-05-080.780.693.73B3.81B
2023-02-270.670.723.88B3.99B
2022-11-070.860.824.08B4.14B
2022-08-080.880.814.12B4.18B
2022-05-090.930.814.19B4.23B
2022-02-280.800.824.34B4.35B
2021-11-080.990.864.54B4.39B
2021-08-090.980.884.58B4.38B
2021-05-100.920.794.43B3.77B
2021-03-010.941.243.62B4.17B
2020-11-061.311.162.97B2.62B
2020-08-061.110.982.73B2.37B
2020-05-110.900.862.62B2.50B
2020-02-271.401.283.19B2.89B
2019-11-051.171.132.96B2.86B
2019-07-291.030.952.85B2.61B
2019-05-070.820.792.50B2.40B
2019-02-261.301.363.08B3.21B
2018-11-051.251.192.86B2.72B
2018-08-081.071.222.81B3.15B
2018-05-090.960.962.68B2.68B
2018-02-281.431.413.24B3.19B
2017-11-061.101.202.99B3.24B
2017-08-091.101.162.96B3.12B
2017-05-100.930.922.72B2.69B

Dividends

Yield 2.31%. Payout ratio —. Frequency Quarterly.

Safety score 87/100 · Safe. Payout ratio is not reported, so this part stays neutral. Dividends use less than 40% of free cash flow. Dividends were paid in 28 separate years. Yield is 2.3%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-11-23$0.122026-11-232026-12-16Quarterly
2026-08-21$0.122026-08-212026-09-16Quarterly
2026-05-22$0.122026-05-222026-06-17Quarterly
2026-03-09$0.122026-03-092026-03-18Quarterly
2025-11-24$0.122025-11-242025-12-15Quarterly
2025-08-22$0.122025-08-222025-09-15Quarterly
2025-05-23$0.122025-05-232025-06-16Quarterly
2025-03-10$0.122025-03-102025-03-18Quarterly
2024-11-22$0.122024-11-222024-12-13Quarterly
2024-08-23$0.122024-08-232024-09-13Quarterly
2024-05-23$0.122024-05-242024-06-14Quarterly
2024-03-08$0.122024-03-112024-03-18Quarterly
2023-11-22$0.122023-11-242023-12-15Quarterly
2023-08-23$0.122023-08-242023-09-15Quarterly
2023-05-23$0.122023-05-242023-06-16Quarterly
2023-03-08$0.122023-03-092023-03-17Quarterly
2022-11-22$0.122022-11-232022-12-16Quarterly
2022-08-23$0.122022-08-242022-09-16Quarterly
2022-05-23$0.122022-05-242022-06-16Quarterly
2022-02-23$0.122022-02-242022-03-16Quarterly
2021-11-22$0.112021-11-232021-12-16Quarterly
2021-08-23$0.112021-08-242021-09-16Quarterly
2021-05-21$0.112021-05-242021-06-16Quarterly
2007-06-27$0.062007-06-292007-07-16Quarterly
2007-03-28$0.062007-03-302007-04-16Quarterly
2006-12-27$0.062006-12-292007-01-16Quarterly
2006-09-27$0.062006-09-292006-10-16Quarterly
2006-06-28$0.062006-06-302006-07-14Quarterly
2006-03-29$0.062006-03-312006-04-17Quarterly
2005-12-28$0.062005-12-302006-01-13Quarterly
2005-09-28$0.062005-09-302005-10-17Quarterly
2005-06-28$0.062005-06-302005-07-15Quarterly
2005-03-29$0.032005-03-312005-04-15Quarterly
2004-12-29$0.032004-12-312005-01-14Quarterly
2004-09-28$0.032004-09-302004-10-15Quarterly
2004-06-28$0.032004-06-302004-07-15Quarterly
2004-03-29$0.032004-03-312004-04-15Quarterly
2003-12-29$0.032003-12-312004-01-15Quarterly
2003-09-26$0.022003-09-302003-10-15Quarterly
2003-06-26$0.022003-06-302003-07-15Quarterly
2003-03-27$0.022003-03-312003-04-15Quarterly
2002-12-27$0.022002-12-312003-01-15Quarterly
2002-09-26$0.022002-09-302002-10-15Quarterly
2002-06-26$0.022002-06-302002-07-15Quarterly
2002-03-26$0.022002-03-292002-04-15Quarterly
2001-12-27$0.022001-12-312002-01-15Quarterly
2001-09-26$0.022001-09-302001-10-15Quarterly
2001-06-27$0.022001-06-302001-07-16Quarterly
2001-03-28$0.022001-03-302001-04-16Quarterly
2000-12-27$0.022000-12-312001-01-15Quarterly
2000-09-27$0.022000-09-302000-10-15Quarterly
2000-06-28$0.022000-06-302000-07-14Quarterly
2000-03-29$0.022000-03-312000-04-15Quarterly
1999-12-29$0.021999-12-312000-01-14Quarterly
1999-09-28$0.021999-09-301999-10-15Quarterly
1999-06-28$0.021999-06-301999-07-15Quarterly
1999-03-29$0.021999-03-311999-04-15Quarterly
1998-12-29$0.021998-12-311999-01-15Quarterly
1998-09-28$0.021998-09-301998-10-15Quarterly
1998-06-26$0.021998-06-301998-07-15Quarterly
1998-03-30$0.021998-04-011998-04-15Quarterly
1997-12-29$0.021997-12-311998-01-15Quarterly
1997-09-26$0.021997-09-301997-10-15Quarterly
1997-06-26$0.021997-06-301997-07-15Quarterly
1997-03-26$0.021997-03-311997-04-15Quarterly
1996-12-30$0.021997-01-021997-01-15Quarterly
1996-09-26$0.021996-09-301996-10-15Quarterly
1996-06-26$0.021996-06-301996-07-15Quarterly
1996-03-27$0.021996-03-311996-04-15Quarterly
1995-12-27$0.021995-12-311996-01-15Quarterly
1995-09-27$0.021995-09-291995-10-13Quarterly
1995-06-29$0.011995-07-031995-07-14Quarterly
1995-03-27$0.011995-03-311995-04-13Quarterly
1994-12-23$0.02——Quarterly
1994-09-26$0.01——Quarterly
1994-06-24$0.01——Quarterly
1994-03-25$0.01——Quarterly
1993-12-27$0.01——Quarterly
1993-09-24$0.01——Quarterly
1993-06-24$0.01——Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-09-30Groothuis Leo FransBuy2.47K$17.7243.75K
2026-09-30SIMMONS DAVID SBuy2.12K$17.7237.51K
2026-08-15Enrietti AndrewBuy25.13K——
2026-08-15Enrietti AndrewBuy999——
2026-08-15Enrietti AndrewSell435$16.237.06K
2026-08-15Enrietti AndrewSell10.93K$16.23177.41K
2026-08-15Enrietti AndrewSell25.13K——
2026-08-15Enrietti AndrewSell998——
2026-06-30SIMMONS DAVID SBuy2.36K$15.8837.51K
2026-06-30Groothuis Leo FransBuy2.76K$15.8843.77K
2026-06-25Campbell PaulSell50.08K$16.17809.78K
2026-04-15Le Goff CorinneBuy39.34K——
2026-04-15Le Goff CorinneBuy3.64K——
2026-04-15Le Goff CorinneSell1.62K$13.8622.41K
2026-04-15Le Goff CorinneSell17.45K$13.86241.86K
2026-04-15Le Goff CorinneSell3.64K——
2026-04-15Le Goff CorinneSell39.34K——
2026-03-23Campbell PaulSell21.35K$13.28283.54K
2026-03-06Le Goff CorinneBuy44.16K——
2026-03-06Le Goff CorinneBuy88.98K——
2026-03-06Le Goff CorinneSell44.16K——
2026-03-06Le Goff CorinneBuy2.19K——
2026-03-06Le Goff CorinneSell973$14.1613.78K
2026-03-06Le Goff CorinneSell19.59K$14.16277.37K
2026-03-06Le Goff CorinneSell2.19K——
2026-03-06Mistras TheodoraBuy41.71K——
2026-03-06Mistras TheodoraBuy86.02K——
2026-03-06Mistras TheodoraSell41.71K——
2026-03-06Mistras TheodoraBuy2.07K——
2026-03-06Mistras TheodoraSell1.15K$14.1616.23K
2026-03-06Mistras TheodoraSell23.07K$14.16326.63K
2026-03-06Mistras TheodoraSell2.07K——
2026-03-06Maletta Matthew JosephBuy59.32K——
2026-03-06SEVERINO MICHAELBuy919——
2026-03-06SEVERINO MICHAELBuy25.11K——
2026-03-06SEVERINO MICHAELBuy15.89K——
2026-03-06SEVERINO MICHAELSell918——
2026-03-06SEVERINO MICHAELSell25.11K——
2026-03-06Enrietti AndrewBuy19.17K——
2026-03-06Enrietti AndrewBuy952——
2026-03-06Enrietti AndrewSell415$14.165.88K
2026-03-06Enrietti AndrewSell8.34K$14.16118.05K
2026-03-06Enrietti AndrewBuy60.44K——
2026-03-06Enrietti AndrewSell19.17K——
2026-03-06Enrietti AndrewSell952——
2026-03-06PARRISH MARK WBuy1.18K——
2026-03-06PARRISH MARK WBuy23.66K——
2026-03-06PARRISH MARK WBuy15.89K——
2026-03-06PARRISH MARK WSell1.17K——
2026-03-06PARRISH MARK WSell23.66K——
2026-03-06Campbell PaulBuy27.60K——
2026-03-06Campbell PaulBuy1.37K——
2026-03-06Campbell PaulSell601$14.168.51K
2026-03-06Campbell PaulSell12.09K$14.16171.17K
2026-03-06MARK RICHARD ABuy1.18K——
2026-03-06MARK RICHARD ABuy23.66K——
2026-03-06Campbell PaulBuy56.73K——
2026-03-06Campbell PaulSell27.60K——
2026-03-06MARK RICHARD ABuy15.89K——
2026-03-06Campbell PaulSell1.37K——
2026-03-06MARK RICHARD ASell1.17K——
2026-03-06MARK RICHARD ASell23.66K——
2026-03-06Smith Scott AndrewBuy124.52K——
2026-03-06Smith Scott AndrewBuy6.18K——
2026-03-06Smith Scott AndrewSell2.43K$14.1634.45K
2026-03-06Smith Scott AndrewSell49.00K$14.16693.83K
2026-03-06Smith Scott AndrewBuy256.07K——
2026-03-06Smith Scott AndrewSell124.52K——
2026-03-06Smith Scott AndrewSell6.18K——
2026-03-06HIGGINS MELINA EBuy1.18K——
2026-03-06HIGGINS MELINA EBuy23.66K——
2026-03-06HIGGINS MELINA EBuy15.89K——
2026-03-06HIGGINS MELINA ESell1.17K——
2026-03-06HIGGINS MELINA ESell23.66K——
2026-03-06Groothuis Leo FransBuy23.66K——
2026-03-06Groothuis Leo FransBuy1.18K——
2026-03-06Groothuis Leo FransSell62$14.16878
2026-03-06Groothuis Leo FransSell1.24K$14.1617.60K
2026-03-06SIMMONS DAVID SBuy524——
2026-03-06SIMMONS DAVID SBuy22.82K——
2026-03-06Groothuis Leo FransBuy15.89K——
2026-03-06SIMMONS DAVID SBuy15.89K——
2026-03-06Groothuis Leo FransSell1.17K——
2026-03-06Groothuis Leo FransSell23.66K——
2026-03-06SIMMONS DAVID SSell523——
2026-03-06SIMMONS DAVID SSell22.82K——
2026-03-06KILTS JAMES MBuy1.18K——
2026-03-06KILTS JAMES MBuy23.66K——
2026-03-06Lyons Dillon JoEllenBuy1.18K——
2026-03-06Lyons Dillon JoEllenBuy23.66K——
2026-03-06Lyons Dillon JoEllenBuy15.89K——
2026-03-06KILTS JAMES MBuy15.89K——
2026-03-06Lyons Dillon JoEllenSell1.17K——
2026-03-06Lyons Dillon JoEllenSell23.66K——
2026-03-06KILTS JAMES MSell1.17K——
2026-03-06KILTS JAMES MSell23.66K——
2026-03-06Vivaldi Coelho RogerioBuy1.18K——
2026-03-06Vivaldi Coelho RogerioBuy23.66K——
2025-11-03SIMMONS DAVID SBuy213$10.432.22K
2025-08-27SIMMONS DAVID SBuy286$10.422.98K

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 880, holders -188 vs prior quarter. Ownership 67.12%.

HolderSharesChangeChange %Value
FMR LLC133.57M36.91M+38.19%2.37B
BLACKROCK, INC.85.22M-795.01K-0.92%1.51B
VANGUARD CAPITAL MANAGEMENT LLC75.18M-863.67K-1.14%1.33B
DAVIS SELECTED ADVISERS72.40M-2.83M-3.76%1.28B
VANGUARD PORTFOLIO MANAGEMENT LLC54.30M22.20K+0.04%962.27M
STATE STREET CORP46.37M-6.69M-12.62%821.76M
GEODE CAPITAL MANAGEMENT, LLC33.04M236.72K+0.72%584.56M
INVESCO LTD.22.05M1.28M+6.14%390.67M
DIMENSIONAL FUND ADVISORS LP17.20M-12.77M-42.61%304.85M
MORGAN STANLEY14.51M-620.42K-4.10%257.09M
BANK OF NEW YORK MELLON CORP12.57M-1.71M-12.00%222.80M
ASSENAGON ASSET MANAGEMENT S.A.10.53M5.54M+111.14%186.66M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP9.18M807.62K+9.65%162.65M
LSV ASSET MANAGEMENT8.39M-168.07K-1.96%148.62M
CALLODINE CAPITAL MANAGEMENT, LP8.30M302.19K+3.78%147.13M
JPMORGAN CHASE & CO6.91M-413.07K-5.64%126.34M
VANGUARD FIDUCIARY TRUST CO6.49M-57.79K-0.88%114.93M
CITIGROUP INC6.14M1.78M+40.79%108.78M
NUVEEN, LLC6.03M22.65K+0.38%106.85M
DEUTSCHE BANK AG\5.99M-1.91M-24.15%106.07M
FRANKLIN TEMPLETON INC5.15M-511.49K-9.04%98.92M
NANTAHALA CAPITAL MANAGEMENT, LLC5.00M00.00%88.60M
SOUND SHORE MANAGEMENT INC /CT/4.59M4.59MNew81.29M
VICTORY CAPITAL MANAGEMENT INC4.03M4.03MNew71.41M
QUBE RESEARCH & TECHNOLOGIES LTD3.75M-2.43M-39.31%66.47M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener